Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Nosh Biofoods | 2024 | Seed | Undisclosed | Berlin |
| ottonova | 2022 | Series F | Undisclosed | Munich |
| HAYA Therapeutics | 2025 | Grant | Undisclosed | Lausanne |
| ImCheck Therapeutics | 2024 | Grant | Undisclosed | Marseille |
| CELUS | 2022 | Series A | Undisclosed | Munich |
| TopK | 2025 | Seed | Undisclosed | San Francisco |
| Isar Aerospace | 2026 | Series D | Undisclosed | Munich |
| Portal Biotech | 2025 | Series A | Undisclosed | London |
| Priothera | 2025 | Grant | Undisclosed | Dublin |
| TILT | 2026 | Series B | $18.1M | London |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Nosh Biofoods | Seed | Undisclosed | Berlin, Germany |
| 2 | ottonova | Series F | Undisclosed | Munich, Germany |
| 3 | HAYA Therapeutics | Grant | Undisclosed | Lausanne, Switzerland |
| 4 | ImCheck Therapeutics | Grant | Undisclosed | Marseille, France |
| 5 | CELUS | Series A | Undisclosed | Munich, Germany |
| 6 | TopK | Seed | Undisclosed | San Francisco, United States |
| 7 | Isar Aerospace | Series D | Undisclosed | Munich, Germany |
| 8 | Portal Biotech | Series A | Undisclosed | London, United Kingdom |
| 9 | Priothera | Grant | Undisclosed | Dublin, Ireland |
| 10 | TILT | Series B | $18.1M | London, United Kingdom |
Nosh Biofoods is a meat producer that employs fermentation technology to provide nutritious and flavorful options for the food sector.
ottonova is Germany's newest and purely digital health insurance
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Engineering platform to automate the development of electronics
TopK is a serverless, cloud-native, document database built for powering search applications.
Isar Aerospace builds and operates launch vehicles for transporting small and medium-sized satellites into Earth’s orbit.
Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.
Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
TILT app is an online shopping platform that allows users to buy through videos, live streams, and earn rewards.
MONA AI is an AI-powered recruitment platform that automates candidate sourcing, screening, matching, and hiring workflows for businesses.
Living Assets: NFT 2.0. Evolving - Scalable - Multicurrency - Sustainable - Certifiable.
eleQtron develops and operates trapped-ion quantum computers built for industrial and scientific use.
EthonAI is an AI-powered platform that detects and prevents manufacturing defects.
Hilo by Aktiia provides a wearable band, calibration cuff, and app for cuffless continuous blood pressure monitoring.
Curio is a platform that allows individuals to stay informed by listening to human-narrated news from reliable publications.
Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.
Pillar is shaping a world where every construction company is resilient and financially sound.
Aiven is a technology-driven company that enables businesses to manage an open-source data infrastructure in the cloud.
The Interaction Company's Poke is an AI assistant that lives fully inside iMessage and integrates seamlessly.
CONXAI develops a no-code artificial intelligence platform to automate knowledge-intensive workflows in the construction industries.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Rivia is a next-gen operating system for improved trial outcomes.
TastyUrban is in the process of developing a new generation of restaurant usage and strategy.
Obligate allows companies to issue on-chain bonds and commercial paper to receive funding from investors in a regulated DeFi environment.
Earlybird Venture Capital has invested in 136 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Earlybird Venture Capital's top investment sectors include Artificial Intelligence (AI), Health Care, Software, Biotechnology, Medical. The firm invests across 60 different industry categories.
Among tracked funding rounds, Polares Medical received $50.0M in a Series C round. Earlybird Venture Capital's total known invested capital is $1.5B.
Earlybird Venture Capital's average investment size is $16.9M across its portfolio of 136 companies.
Recent Earlybird Venture Capital portfolio additions include Nosh Biofoods, ottonova, HAYA Therapeutics, ImCheck Therapeutics, CELUS. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors